Mar 20 |
Evogene Reports Receipt of Nasdaq Minimum Bid Price Notification
|
Mar 19 |
Bayer AG and Lavie Bio Continue for Second Year of Biofungicides Validation Following Successful Lab and Greenhouse Testing
|
Mar 8 |
Evogene Ltd. (NASDAQ:EVGN) Q4 2023 Earnings Call Transcript
|
Mar 7 |
Evogene Ltd. (EVGN) Q4 2023 Earnings Call Transcript
|
Mar 7 |
Evogene (EVGN) Reports Q4 Loss, Misses Revenue Estimates
|
Mar 7 |
Evogene GAAP EPS of -$0.13 beats by $0.01, revenue of $0.58M misses by $0.31M
|
Mar 7 |
Evogene Reports Fourth Quarter and Full Year 2023 Financial Results
|
Mar 7 |
Earnings Scheduled For March 7, 2024
|
Mar 6 |
Evogene Q4 2023 Earnings Preview
|
Mar 6 |
AgPlenus Achieves Milestone in Collaboration with Corteva to Develop Novel Herbicides
|